Table 6.

2015 ATA dosing guidelines for radioactive iodine therapy.

Dose	Site of disease
30–50 mCi	Remanent ablation
50–150 mCi	Loco-regional positive disease including nodal or metastatic disease
100–200 mCi	Lung and bone metastatic disease